Additionally, STING-LNPs achieved the induction of therapeutic effects in the case of lung metastasis by a B16-F10 melanoma that was resistant to anti-PD-1 antibody treatment and, with anti-PD-1 antibody, exerted a synergistic effect [11,12]. The gene discussed is STING1; the disease is melanoma.